Systemic sclerosis causes 1 in 2 deaths within 4 years of diagnosis
A S$6 million grant at the Singapore General Hospital will fund a new project for systemic sclerosis patients. The aim is to better diagnosis and personalised treatment for the disease that has poor survival rates, killing one in two Asian patients within four years of diagnosis. Researchers will analyse patients' genes, immune systems, gut bacteria and more over the next five years. Associate Professor Andrea Low, Lead of the Singapore Systemic Sclerosis Precision Medicine Project and Senior Consultant at SGH, explains why Asian patients have poor survival rates with this disease and the factors contributing to it. She also points out how the Singapore Systemic Sclerosis Precision Medicine Project differs from existing programmes treating this disease.
A S$6 million grant at the Singapore General Hospital will fund a new project for systemic sclerosis patients. The aim is to better diagnosis and personalised treatment for the disease that has poor survival rates, killing one in two Asian patients within four years of diagnosis. Researchers will analyse patients' genes, immune systems, gut bacteria and more over the next five years. Associate Professor Andrea Low, Lead of the Singapore Systemic Sclerosis Precision Medicine Project and Senior Consultant at SGH, explains why Asian patients have poor survival rates with this disease and the factors contributing to it. She also points out how the Singapore Systemic Sclerosis Precision Medicine Project differs from existing programmes treating this disease.
Popular Shows
